Prognostic significance of the preoperative alkaline phosphatase‑to‑albumin ratio in patients with hepatocellular carcinoma after hepatic resection

Oncol Lett. 2023 Mar 1;25(4):147. doi: 10.3892/ol.2023.13733. eCollection 2023 Apr.

Abstract

This study aimed to investigate the prognostic value of the preoperative alkaline phosphatase-to-albumin ratio (APAR) in patients with hepatocellular carcinoma (HCC) who underwent radical hepatectomy. The clinicopathological data from 330 patients was retrospectively analyzed. Receiver operating characteristic curves of APAR for diagnostic tumor recurrence were plotted with a cut-off value of 1.74. A high preoperative APAR value was significantly associated with hepatitis B surface antigen level, tumor diameter, and tumor-node-metastasis stage. The disease-free survival (DFS) and overall survival (OS) of patients with a high preoperative APAR were shorter than those with a low APAR. The independent risk factors for DFS were an APAR ≥1.74, and macrovascular invasion or tumor thrombus. The independent risk factors for OS were an APAR ≥1.74, existing clinical symptoms, α-fetoprotein level ≥20 ng/ml, macrovascular invasion or tumor thrombus, and family history of cancer. In conclusion, a preoperative APAR (≥1.74) is an independent risk factor influencing the poor prognosis of patients with HCC after curative hepatectomy, and patients with such a result should be closely monitored.

Keywords: alkaline-phosphatase-to-albumin ratio; hepatectomy; hepatocellular carcinoma; prognosis; survival rate.

Grants and funding

This work was financially supported by the National High-tech R&D (863) Program of China (grant no. SS2015AA020408), Fundamental Research Funds of Central Universities (grant no. 2042022kf1076), Natural Science Foundation of Hubei Province (grant on. 2020CFB659), and the Research Foundation of Hubei Provincial Health Commission (grant no. WJ2021M139).